glp 1 breast feeding Can you take GLP-1 while breastfeeding? What the research actually shows Support GLP-1 Postpartum – MilkDust

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department

And if I think like, oh, this is like cardiovascular disease, then then we need to be focusing there, not waiting until things change

Body Composition Individuals with higher body fat percentages may experience a slower onset of effects compared to those with lower body fat, as the medication interacts with body systems differently

The SUSTAIN and STEP trial programs for semaglutide, involving thousands of participants followed for up to two years, did not demonstrate an increased overall cancer risk compared to placebo groups

ZImmunitatsforsch 2: 651, 1909

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial